[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 2188 Introduced in Senate (IS)]
<DOC>
114th CONGRESS
1st Session
S. 2188
To amend the Federal Food, Drug, and Cosmetic Act with respect to the
humanitarian device exemption.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
October 21, 2015
Mr. Gardner (for himself and Mr. Donnelly) introduced the following
bill; which was read twice and referred to the Committee on Health,
Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To amend the Federal Food, Drug, and Cosmetic Act with respect to the
humanitarian device exemption.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Rare Disease Innovation Act''.
SEC. 2. HUMANITARIAN DEVICE EXEMPTION APPLICATION.
(a) In General.--Section 520(m) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 360j) is amended--
(1) in paragraph (1) by striking ``fewer than 4,000'' and
inserting ``not more than 8,000'';
(2) in paragraph (2)(A) by striking ``fewer than 4,000''
and inserting ``not more than 8,000''; and
(3) in paragraph (6)(A)(ii), by striking ``4,000'' and
inserting ``8,000''.
(b) Guidance Document on Probable Benefit.--Not later than 18
months after the date of enactment of this Act, the Secretary of Health
and Human Services, acting through the Commissioner of Food and Drugs,
shall publish a draft guidance document that defines the criteria for
establishing ``probable benefit'' as that term is used in section
520(m)(2)(C) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
360j(m)(2)(C)).
(c) Reports to Congress.--Five years after the date of enactment of
this Act and every 5 years thereafter, the Secretary of Health and
Human Services shall submit to Congress a report on the effect of the
amendments made by subsection (a).
<all>